| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |